BiomX, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Accounting Policies, by Policy (Policies)
Notes Tables
Notes Details

Basic and Diluted Loss Per Share (Details)

v3.24.1.1.u2

Basic and Diluted Loss Per Share (Details) - $ / shares	3 Months Ended
Basic and Diluted Loss Per Share (Details) - $ / shares	Mar. 31, 2024	Mar. 15, 2024	Mar. 31, 2023
Fully Vested Warrants [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Number of shares issued warrants	2,974
Fully Vested Pre-Funded Warrants [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Number of shares issued warrants	9,832,449		2,776,429
Underlying Options [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Anti-dilutive shares	5,193,348
Underlying Warrants [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Anti-dilutive shares	126,461,307
Contingent Shares [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Anti-dilutive shares	2,000,000
Redeemable Convertible Preferred Sares [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Anti-dilutive shares	256,887,000
Common Stock [Member]
Basic and Diluted Loss Per Share (Details) [Line Items]
Exercise price (in Dollars per share)	$ 0.001	$ 5

- References

No definition available.

+ Details

Name:	phge_BasicandDilutedLossPerShareDetailsLineItems
Namespace Prefix:	phge_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=phge_FullyVestedWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=phge_FullyVestedPreFundedWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=phge_UnderlyingOptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=phge_UnderlyingWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=phge_ContingentSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=phge_RedeemableConvertiblePreferredSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: